Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis
Conclusions:
These observations identify a potential role for liraglutide in the prevention of cardiac fibrosis and identify molecular mechanisms associated with these effects.
Source: Diabetes and Vascular Disease Research - Category: Endocrinology Authors: Gaspari, T., Brdar, M., Lee, H. W., Spizzo, I., Hu, Y., Widdop, R. E., Simpson, R. W., Dear, A. E. Tags: Original Articles Source Type: research
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Hypertension | Nutrition | Obesity | Study | Victoza